Oncology
2301 articles · 70 journals
Journals in this subcategory (70)
- Blood Neoplasia · Elsevier (95)
- European Journal of Surgical Oncology · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (88)
- The Lancet Oncology · Elsevier (88)
- Brachytherapy · Elsevier (86)
- Cancer Epidemiology · Elsevier (85)
- International Journal of Gynecological Cancer · Elsevier (83)
- Journal of Thoracic Oncology · Elsevier (82)
- EJC Skin Cancer · Elsevier (81)
- Lung Cancer · Elsevier (73)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Critical Reviews in Oncology/Hematology · Elsevier (69)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (64)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (63)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Blood Reviews · Elsevier (54)
- Cancer Letters · Elsevier (53)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (20)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Radiologic phenotype and the size dependence of adverse histologic features and recurrence in resected lung adenocarcinoma
- Environmental asbestos exposure and lung cancer burden: Considerations of the dose–response
- Lung cancer detection beyond screening eligibility through an incidental lung nodule program
- Heterogeneous response and progression patterns during tarlatamab therapy in relapsed small cell lung cancer
- Coexistence of Osimertinib-Resistant and Osimertinib-Sensitive cell states in an EGFR-Mutant NSCLC model derived at osimertinib resistance
- T cell dysfunction associated with repeated CAR-T cell manufacturing failure following prolonged bispecific antibody exposure: a case report
- Patient factors affecting unplanned admission or emergency department attendance following systemic anti-cancer therapy for advanced non-small cell lung cancer: A population-based retrospective cohort study
- Mixed-phenotype acute leukemia: Flow cytometric analysis in a tertiary care center of Bangladesh
- TIF1/TRIM24::FGFR1-rearranged myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusion presenting as mixed-phenotype acute leukemia: a case report
- Substituting pegaspargase with recombinant Erwinia asparaginase after hypersensitivity reactions: case series of Canadian adult patients with acute lymphoblastic leukemia
- Clinicopathologic spectrum of PHF6 mutation across a heterogeneous cohort of myeloid malignancies: A single institution experience
- Exponential growth and slow-growing tumours in screen-detected lung cancers: findings from the NELCIN-B3 LDCT screening study in China
- Ferritin provides prognostic information beyond the iCPSS and BLAST-Mol in patients with CMML
- Characteristics and outcomes of patients with advanced or metastatic non–small cell lung cancer harboring a HER2-activating mutation: a real-world retrospective cohort study using a US clinico-genomic database
- Historical and projected smoking patterns and lung cancer incidence across sex and birth-cohorts in Spain: The rising burden in women
- Treatment-cycle–resolved peripheral blood T-cell GP73 dynamics are associated with clinical benefit during PD-1/PD-L1 inhibitor-based therapy in NSCLC
- Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia
- Approval-standardized postmarketing safety reporting phenotypes of talquetamab versus BCMA-directed bispecific antibodies in multiple myeloma
- NGS-based retrospective profiling of BCR::ABL1 kinase domain mutations in chronic myeloid leukemia: Findings from the largest South Asian cohort
- Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study
- Financial burden to patients and informal carers of myelodysplastic syndromes in England: a modelled analysis stratified by transfusion dependence
- A randomized comparison of CPX-351 and FLAG-Ida in high-risk myelodysplastic syndrome: A subgroup analysis of UK NCRI AML19
- Pediatric-inspired USC-ALL regimen vs hyper-CVAD in adults with Ph-negative and Ph-like acute lymphoblastic leukemia
- Prolonged, transplant-free remission with tagraxofusp in combination with venetoclax for transplant-ineligible blastic plasmacytoid dendritic cell neoplasm
- Megakaryopoiesis and its dysregulation in paediatric acute megakaryoblastic leukaemia
- Real-world outcomes of asciminib versus first- and second-generation tyrosine kinase inhibitors as second-line treatment for chronic-phase chronic myeloid leukemia
- Bone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma
- Acute monocytic leukemia with t(8;22)(p11;q11)/BCR::FGFR1, trisomy 8, and concurrent RUNX1/STAG2 mutations: A rare case report and literature review
- The prognostic value of KRAS, NRAS, and BRAF genes mutations in patients with newly diagnosed multiple myeloma
- CD20 antibody–based combination therapy may reduces the adverse prognostic impact of M-protein positivity in marginal zone lymphoma